Cargando…
Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC
BACKGROUND: Immunotherapy has become increasingly important in the perioperative period of non-small-cell lung cancer (NSCLC). In this study, we intended to develop a mutation-based model to predict the therapeutic effificacy of immune checkpoint inhibitors (ICIs) in patients with NSCLC. METHODS: Ra...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998990/ https://www.ncbi.nlm.nih.gov/pubmed/36910641 http://dx.doi.org/10.3389/fonc.2023.1089179 |